Brief: Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen as CEO and Director
04/01/2022 12:20
Jan 4 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* ANEBULO PHARMACEUTICALS NAMES BIOTECHNOLOGY INDUSTRY
EXECUTIVE
SIMON ALLEN AS CEO AND DIRECTOR
Source text for Eikon: ID:nBw72D1zwa
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Anebulo Pharmaceuticals
See all newsAdvisory: Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn
Anebulo Pharmaceuticals Q2 net loss narrows
Brief: Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC
Anebulo Pharmaceuticals posts Q1 net loss
Brief: Anebulo Pharmaceuticals Reports Fourth Quarter And Fiscal Year 2025 Financial Results